ERBB2 and breast carcinoma: The molecular biomarkers estrogen receptor alpha (ER) and human epidermal growth factor receptor 2 (HER2), initially linked to prognosis in primary breast cancer, are routinely used for prognostication and treatment prediction in MBC.